Berylson Capital Partners’s GeneDx Holdings WGS Stock Holding History

Berylson Capital Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-44,424	Closed	-$11.1M	–	36
2021 Q3	$11.1M	Buy	+44,424	New	+$15.3M	5.15%	5

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Berylson Capital Partners's WGS Position: Q4 2021 in Review

Berylson Capital Partners sold out of GeneDx Holdings (WGS) in Q4 2021, closing a stake of 44,424 shares — an estimated $11.1M sold.

Berylson Capital Partners first reported a position in WGS in Q3 2021 and held it in 1 quarter. The position peaked at $11.1M in Q3 2021. 112 funds tracked by Wall St. Rank hold WGS as of Q4 2021.

Berylson Capital Partners reported no remaining GeneDx Holdings position as of Q4 2021 after selling out during the quarter.
Berylson Capital Partners sold 44,424 GeneDx Holdings shares in Q4 2021, an estimated $11.1M.
Berylson Capital Partners first reported a position in GeneDx Holdings in Q3 2021 and held it in 1 quarter.
Berylson Capital Partners's GeneDx Holdings position peaked at $11.1M in Q3 2021.
112 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2021.

Based on Berylson Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.